Product NDC: | 50580-539 |
Proprietary Name: | Sudafed |
Non Proprietary Name: | Naproxen sodium and Pseudoephedrine Hydrochloride |
Active Ingredient(s): | 220; 120 mg/1; mg/1 & nbsp; Naproxen sodium and Pseudoephedrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50580-539 |
Labeler Name: | McNeil Consumer Healthcare Div. McNeil-PPC, Inc |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA076518 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101101 |
Package NDC: | 50580-539-16 |
Package Description: | 2 BLISTER PACK in 1 CARTON (50580-539-16) > 8 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
NDC Code | 50580-539-16 |
Proprietary Name | Sudafed |
Package Description | 2 BLISTER PACK in 1 CARTON (50580-539-16) > 8 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK |
Product NDC | 50580-539 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Naproxen sodium and Pseudoephedrine Hydrochloride |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20101101 |
Marketing Category Name | ANDA |
Labeler Name | McNeil Consumer Healthcare Div. McNeil-PPC, Inc |
Substance Name | NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE |
Strength Number | 220; 120 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |